Trial will evaluate the Durablate catheter in treating patients with ventricular arrhythmias who are resistant to antiarrhythmic drugs or standard ablation.
Shows that coronary angioplasties using the R-One robot are safe and effective for patients, while also improving working conditions for cardiologists.